Company Snapshot

Investment Thesis

Becton Dickinson manufactures medical devices, diagnostics, and bioscience tools used globally. Scale distribution, recurring consumables, and new platforms (Wearable Injectors, robotics) support mid-single-digit growth.

  • Consumables Base: Syringes, catheters, and diagnostics provide recurring revenue.
  • Innovation Pipeline: Wearable drug delivery and robotic biopsy systems drive premium mix.
  • Emerging Markets: Local manufacturing and partnerships accelerate adoption.

Strategic Mix

BD Medical Medication delivery, pharma systems, diabetes care
BD Life Sciences Diagnostics, specimen management, and biosciences
BD Interventional Surgery, peripheral intervention, and urology
Services Installation, training, and digital informatics

Mix mirrors BD’s segment reporting across Medical, Life Sciences, and Interventional.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Post-COVID Normalization

Core growth transitions from pandemic testing to chronic disease care.

Manufacturing Efficiency

Automation and network redesign protect margins despite inflation.

M&A Focus

Bolt-ons in medtech and diagnostics enhance growth platforms.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...